Decision making process, programmatic and logistic impact of the transition from a single-dose vial to a multi-dose vial of the 13-valent pneumococcal vaccine in Benin.

Landry Kaucley, Téné-Alima Essoh, G Patrick Ilboudo, Daleb Abdoulaye Alfa, Modibo Dicko, Rock A Houngnihin, Alexis Satoulou-Maleyo, Franck H Bété, Didier C Agossadou

Vaccine 2020 Oct 07

filter terms:

Benin, a country eligible for Gavi support, changed the presentation of the 13-valent pneumococcal vaccine (PCV13) from the single-dose vial (SDV) to the multi-dose vial (MDV). The present work aims to evaluate the process of making this decision as well as programmatic and logistic impacts. WHO protocol for post-introduction evaluation (PIE) was used. Programmatic impact was evaluated by comparing PCV13 coverage and dropout rates with a comparator vaccine administered simultaneously over similar 6-month periods prior to and after the transition. This impact was also appreciated from observation of multi-dose vial management practices during immunization sessions. Logistic impact was measured from the analysis of storage capacities, waste management and vaccine losses. Decision to move to PCV13 MDV was taken at EPI level. Activities planned to support this switch were partially implemented. Impact on vaccination coverage and PCV13 dropout rates in relation with the transition to PCV13 MDV was not detected. The study found that 63% of the health staff surveyed knew and applied WHO's multidose vial policy (MDVP). Vaccines opened vials were found in 83% of health facilities visited. PCV13 MDV (37%) was one of the 3 main vaccines found with open vials in health facility refrigerators. Vaccination risky practices were observed during immunization sessions in 83% of health facilities. The main risky practice was the lack of indication of the date and hour of opening vials (56%). There was a reduction of the volume occupied by vaccines at central store by 47%. Net storage volume per fully immunized child (FIC) decreased from 69.5 to 41 m3. PCV13 MDV allows for 40% reduction in the amount of waste produced by vaccination. PCV13 open vial loss rate has increased from 3 to 7%. Benin's experience in transition to an MDV presentation of PCV13 reveals the need for better preparation and planning. Copyright © 2020. Published by Elsevier Ltd.

Citation

Landry Kaucley, Téné-Alima Essoh, G Patrick Ilboudo, Daleb Abdoulaye Alfa, Modibo Dicko, Rock A Houngnihin, Alexis Satoulou-Maleyo, Franck H Bété, Didier C Agossadou. Decision making process, programmatic and logistic impact of the transition from a single-dose vial to a multi-dose vial of the 13-valent pneumococcal vaccine in Benin. Vaccine. 2020 Oct 07;38(43):6807-6813